Monomer

Aduro Clean Technologies Provides Update on Joint Western University Research Project

Retrieved on: 
Thursday, April 4, 2024
ACT, Western University, Oil, Benchmarking, Recycling, Partnership, LDPE, Knowledge, Monomer, Research, Pyrolysis, PP, Mentorship, Behavior, Chemistry, Plastic, Chemical substance, HDPE, HCT

Over the duration of the project, the research program will employ a total of 19 highly skilled research members and engineers.

Key Points: 
  • Over the duration of the project, the research program will employ a total of 19 highly skilled research members and engineers.
  • Building on our commitment to nurturing talent, Aduro has already offered positions to outstanding graduates from the project, enabling them to continue their impactful work as full-time Aduro employees.
  • “We are happy to provide this update and report on the significant project progress to date.
  • The synergistic relationship we've cultivated with Western University, is not only advancing critical research but also fostering the next generation of scientific leaders to join our team,” stated Ofer Vicus, CEO of Aduro.

Olin Announces New CEO

Retrieved on: 
Monday, February 19, 2024
Monomer, Hydrochloric acid, Olin Corporation, Growth, BASF, Hydrogen, Chlorine, University, OLN, Executive, Clemson University, LyondellBasell, Plastic, Polyurethane, Law enforcement, BP, Management

CLAYTON, Mo., Feb. 19, 2024 /PRNewswire/ -- Olin Corporation (NYSE: OLN) today announced the Board of Directors has appointed Kenneth Lane as President and Chief Executive Officer and Director of Olin Corporation effective March 18, 2024.

Key Points: 
  • CLAYTON, Mo., Feb. 19, 2024 /PRNewswire/ -- Olin Corporation (NYSE: OLN) today announced the Board of Directors has appointed Kenneth Lane as President and Chief Executive Officer and Director of Olin Corporation effective March 18, 2024.
  • Olin also announced Mr. Sutton stepped down as Executive Chairman of the Board of Directors, and William Weideman was appointed Chairman, effective February 16, 2024.
  • "I am honored and excited to lead Olin Corporation and build on its strong foundation.
  • Olin Corporation is a leading vertically integrated global manufacturer and distributor of chemical products and a leading U.S. manufacturer of ammunition.

BASF and Carlisle Construction Materials partner on product exploration of InsulBase/VersiCore Polyiso insulation boards with zero carbon footprint MDI: Lupranate ZERO

Retrieved on: 
Wednesday, January 17, 2024
Senior, Carbon footprint, CO2, MDI, Science, Monomer, Carbon, PCF, PIR, LEED, Science Based Targets initiative, WDC, Construction, ZERO, Marketing, GHG, BASF, Renewable energy

FLORHAM PARK, N.J. and CARLISLE, Pa., Jan. 17, 2024 /PRNewswire-PRWeb/ -- BASF and Carlisle Construction Materials have announced a collaboration using Lupranate® ZERO, the world's first isocyanate with a zero carbon footprint. Lupranate ZERO (ZERO stands for Zero Emissions Renewable Origins) is used to produce MDI polyisocyanurate boards (PIR or polyiso) and rigid polyurethane foam for the thermal insulation of buildings. This is of particular interest to the construction industry, and as the leading polyiso manufacturer, Carlisle is the natural partner to explore this technology.

Key Points: 
  • Carlisle Construction Materials exploring Lupranate ZERO in production of InsulBase/VersiCore polyisocyanurate insulation boards.
  • FLORHAM PARK, N.J. and CARLISLE, Pa., Jan. 17, 2024 /PRNewswire-PRWeb/ -- BASF and Carlisle Construction Materials have announced a collaboration using Lupranate® ZERO, the world's first isocyanate with a zero carbon footprint.
  • Lupranate ZERO (ZERO stands for Zero Emissions Renewable Origins) is used to produce MDI polyisocyanurate boards (PIR or polyiso) and rigid polyurethane foam for the thermal insulation of buildings.
  • By exploring Lupranate ZERO with net-zero emissions, Carlisle Construction Materials is continuing its category-leading legacy in sustainability.

ProMIS Neurosciences to Present New Preclinical Data for PMN310 at AD/PD 2023

Retrieved on: 
Monday, March 13, 2023
Plaque, Multiple system atrophy, PMN, Conference, ALS, MSA, TSX, Monomer, AD, DSM-IV codes, International Conference on Learning Representations, Therapy

TORONTO, Ontario and CAMBRIDGE, Massachusetts, March 13, 2023 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (TSX: PMN) (Nasdaq: PMN), a biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), today announced that new preclinical data for ProMIS’ lead candidate for AD, PMN310, will be presented as a virtual short oral poster presentation at the International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2023) to be held on March 28-April 1, 2023 virtually and in Gothenburg, Sweden.

Key Points: 
  • TORONTO, Ontario and CAMBRIDGE, Massachusetts, March 13, 2023 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (TSX: PMN) (Nasdaq: PMN), a biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), today announced that new preclinical data for ProMIS’ lead candidate for AD, PMN310, will be presented as a virtual short oral poster presentation at the International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2023) to be held on March 28-April 1, 2023 virtually and in Gothenburg, Sweden.
  • Title: Differentiation of PMN310 from Other Amyloid-Beta-Directed Antibodies: Ability to Selectively Target Toxic Brain Oligomers Despite Competing Monomers and Plaque
    The virtual poster (P0214) will be available during the AD/PD 2023 medical conference starting March 28, 2023 and available on ProMIS’ website.

Aduro Clean Technologies Provides Update on Joint Research Initiative with Western University

Retrieved on: 
Thursday, February 2, 2023
ACT, University, FSE, Plastic, Literature, Plasticizer, Solvent, Monomer, Partnership, CSE, National Science Foundation, Fluid mechanics, Food, NSERC, Oil, Solubility, Research, Western University, Mitacs

All intellectual property generated from the joint research project will be owned by Aduro.

Key Points: 
  • All intellectual property generated from the joint research project will be owned by Aduro.
  • Aduro will communicate with the Western University team on a bi-weekly basis to ensure the project's success.
  • The three-year research project, led by Dr. Paul A. Charpentier and Dr. Cedric L. Briens of Western University, began in January 2023.
  • “We warmly welcome the new researchers from Western University and are grateful for the support of NSERC and Mitacs.

EQS-News: Aduro Clean Technologies Provides Update on Joint Research Initiative with Western University

Retrieved on: 
Thursday, February 2, 2023
ACT, Mitacs, Sarnia, University, Oil, Literature, Solvent, CSE, FSE, National Science Foundation, Solubility, Partnership, Plasticizer, NSERC, Monomer, Research, Plastic, Food, Western University

On October 27, 2022, the Company in partnership with the University of Western Ontario (“Western University”) announced that its joint research project was awarded $1.15 million in non-repayable funds by the National Sciences and Engineering Research Council ("NSERC") Alliance and Mitacs Accelerate Grants Program (“Mitacs”).

Key Points: 
  • On October 27, 2022, the Company in partnership with the University of Western Ontario (“Western University”) announced that its joint research project was awarded $1.15 million in non-repayable funds by the National Sciences and Engineering Research Council ("NSERC") Alliance and Mitacs Accelerate Grants Program (“Mitacs”).
  • All intellectual property generated from the joint research project will be owned by Aduro.
  • Aduro will communicate with the Western University team on a bi-weekly basis to ensure the project's success.
  • The three-year research project, led by Dr. Paul A. Charpentier and Dr. Cedric L. Briens of Western University, began in January 2023.

Aduro Announces Award of $1.15 Million Joint NSERC Alliance-Mitacs Grant in Partnership with Western University

Retrieved on: 
Thursday, October 27, 2022
ACT, R, Food, Company, University, Western University, Mechanical, Chemistry, Government, Oil, HST, Doctor of Philosophy, Alliance, Mitacs, Department, Biochemical engineering, Student, CSE, Technology, HCT, Leadership, National Science Foundation, Research, GLOBE, Monomer, Master of Engineering, Plasticizer, NSERC, Water, Knowledge, Alternative, Plastic, FSE, Institute, Partnership, Management, Pharmaceutical industry, Engineering

Over the duration of the project, Aduro will contribute $382,500 (plus HST) with NSERC and Mitacs contributing a total of $1,147,500.

Key Points: 
  • Over the duration of the project, Aduro will contribute $382,500 (plus HST) with NSERC and Mitacs contributing a total of $1,147,500.
  • In addition to the grant funding, through the partnership with Western University, the project provides very cost-effective access to state-of-the-art laboratory facilities, reactors, and analytical equipment.
  • The project is a great opportunity to again collaborate with Aduro, said Dr. Paul Charpentier, Professor at Western University.
  • We are honored and excited to once again collaborate with Western University and professors Dr. Paul Charpentier and Dr. Cedric L. Briens.

Cruiser Capital Sends Letter to American Vanguard Stockholders

Retrieved on: 
Wednesday, May 25, 2022
Other Professional Services, Professional Services, Finance, Union Carbide, U.S. Securities and Exchange Commission, SPB, Chemical engineering, Pepperdine University, Metamorphosis, BS, Participation, University, Cruiser, AVD, Dow Chemical Company, SEC, LLC, Polyurethane, Additive, Investment, Nature, TSX, Board, Proxy, Silicon, NYSE, Monomer, Company, VP, National Science Foundation, HSC, BLUE, EMT, Info, American Vanguard Corporation, Nomination, Hemlock Semiconductor Corporation, Yale University, Notre Dame, Security (finance), MBA, History, Moses Austin, DOW, Leadership, Ashland Global, NASDAQ, Glass, OF, Person, ISS, CEO, Management

Mr. Rosenbloom is the co-founder of Cruiser Capital Advisors, LLC, which acts as the investment advisor to pooled investment vehicles on a discretionary basis.

Key Points: 
  • Mr. Rosenbloom is the co-founder of Cruiser Capital Advisors, LLC, which acts as the investment advisor to pooled investment vehicles on a discretionary basis.
  • Cruiser Capital Master Fund LP is sending a definitive proxy statement, BLUE proxy card and related proxy materials to shareholders of the Company seeking their support of the Nominees at the Companys 2022 Annual Meeting of Stockholders.
  • Stockholders may obtain a free copy of the definitive proxy statement and BLUE proxy card and other documents filed with the Securities and Exchange Commission (SEC) by Cruiser Capital and its affiliates (the Cruiser Capital Parties) at the SECs web site at www.sec.gov .
  • The definitive proxy statement and other related SEC documents filed with the SEC by the Cruiser Capital Parties may also be obtained free of charge from the Cruiser Capital Parties, upon request.

UV Curable Resins and Formulated Products Market, Forecast to 2026 - Featuring Profiles of Key Competitors, Including Allnex Netherlands, Alberdingk Boley, BASF, and Covestro Among Others - ResearchAndMarkets.com

Retrieved on: 
Tuesday, February 1, 2022
Technology, Chemicals, Plastics, Other Technology, Manufacturing, Growth, USD, UV, Acrylate, Surfactant, Titanium, Adhesive, Environment, Urethane, Technology, COVID-19, CAGR, VOC, Oligomer, Monomer, Region, Volatile organic compound, Composition, Industry, Electronics, Paint, 3D printing, Chemistry

The negative impact of the COVID-19 pandemic on the end-use applications has affected the UV curable resins and formulated products market adversely.

Key Points: 
  • The negative impact of the COVID-19 pandemic on the end-use applications has affected the UV curable resins and formulated products market adversely.
  • APAC is the largest UV curable resins and formulated products market in terms of both value and volume.
  • The region offers significant commercial opportunities for the growth of the UV curable resins and formulated products market.
  • Due to COVID-19, UV curable resins and formulated products producers and numerous companies have halted their production sites across various countries that has led to reduced demand for UV curable resins and formulated products, which affected the demand in APAC countries.

SK Capital Announces Acquisition of the Monomers, Polymers and European Businesses of Deltech Holdings LLC

Retrieved on: 
Monday, August 23, 2021
Other Manufacturing, Finance, Chemicals, Plastics, Banking, Professional Services, Manufacturing, Health, Pharmaceutical, General Health, Industry, Company, Para, PMS, LLC, Growth, Ownership, Acquisition, Plant, Baton Rouge Area Foundation, VT, Director, Baton Rouge, Louisiana, Polymer, Board, CEO, Organization, DVB, Capital, Resin, Monomer

Funds advised by SK Capital Partners, LP (SK Capital), a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, today announced the acquisition of the Monomers, Polymers and European businesses of Deltech Holdings, LLC (Deltech or the Company).

Key Points: 
  • Funds advised by SK Capital Partners, LP (SK Capital), a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, today announced the acquisition of the Monomers, Polymers and European businesses of Deltech Holdings, LLC (Deltech or the Company).
  • Deltech is a world leader in the production of high-performance aromatic monomers and specialized crystal polystyrene, said Mario Toukan, a Managing Director at SK Capital.
  • Bob Elefante stated, SK Capital is the ideal partner given its track record of successfully supporting the growth of entrepreneur-owned businesses in the specialty chemicals industry.
  • SK Capital is a private investment firm with a disciplined focus on the specialty materials, chemicals and pharmaceuticals sectors.